• Info
  • Insider Ownership

Insider Trading & Ownership of Stuart A. Arbuckle

Location
Cambridge, MA
Summary
The estimated net worth of Stuart A. Arbuckle is at least $29,105,152 dollars as of 12 Jan 2026. Stuart A. Arbuckle is the EVP, COO of VERTEX PHARMACEUTICALS INC / MA and owns shares of VERTEX PHARMACEUTICALS INC / MA (VRTX) stock worth about $28.59M. Stuart A. Arbuckle is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $412.8K. Stuart A. Arbuckle is the Director of ImmunoGen, Inc. and owns shares of ImmunoGen, Inc. stock worth about $101.7K.
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Stuart A. Arbuckle files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Stuart A. Arbuckle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRTX VERTEX PHARMACEUTICALS INC / MA Evp, Coo $28,590,654 01 Jul 2025
RYTM RHYTHM PHARMACEUTICALS, INC. Director $412,790 24 Jun 2025
IMGN ImmunoGen, Inc. Director $101,708 12 Feb 2024
ALNY ALNYLAM PHARMACEUTICALS, INC. Director 05 Jan 2026
PRAX Praxis Precision Medicines, Inc. Director 08 Jan 2026

Insider Transactions Reported by Stuart A. Arbuckle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.